2020-12-16
Current Challenges in Health Technology Assessment: Assessing costs and cost-effectiveness of novel treatments in haemato-oncology
Publication
Publication
Uitdagingen bij het beoordelen van gezondheidstechnologieën: Het berekenen van kosten en kosteneffectiviteit van nieuwe behandelingen in de hemato-oncologie
| Additional Metadata | |
|---|---|
| C.A. Uyl-de Groot (Carin) , H.M. Blommestein (Hedwig) | |
| Erasmus University Rotterdam | |
| hdl.handle.net/1765/131305 | |
| Organisation | Erasmus School of Health Policy & Management (ESHPM) |
|
Thielen, F. (2020, December 16). Current Challenges in Health Technology Assessment: Assessing costs and cost-effectiveness of novel treatments in haemato-oncology. Retrieved from http://hdl.handle.net/1765/131305 |
|
| Additional Files | |
|---|---|
| propositions-5f7efa1ae5203.pdf , 94kb | |
| 131305_Chapter_1-General_introduction.pdf Final Version , 202kb | |
| 131305_Chapter_2-How_to_prepare_a_systematic_review_of_ec.pdf Final Version , 372kb | |
| 131305_Chapter_3-Cost_of_Health_Care_for_Paediatric_Patie.pdf Final Version , 293kb | |
| 131305_Chapter_4-Second_line_treatment_for_acute_graft_ve.pdf Final Version , 423kb | |
| 131305_Chapter_5-Cost-Effectiveness_of_Anti-CD19_Chimeric.pdf Final Version , 652kb | |
| 131305_Chapter_6-Cost-effectiveness_of_lenalidomide_plus.pdf Final Version , 682kb | |
| 131305_Chapter_7-Obinutuzumab_in_combination_with_chemoth.pdf Final Version , 233kb | |
| 131305_Chapter_8-Health_Economic_Aspects_of_Chimeric_Anti.pdf Final Version , 609kb | |
| 131305_Chapter_9-General_discussion.pdf Final Version , 221kb | |
| 131305_References.pdf Final Version , 260kb | |
| 131305_Summary.pdf Final Version , 154kb | |
| 131305_Nederlandse_samenvatting.pdf Final Version , 160kb | |
| 131305_About_the_author.pdf Final Version , 134kb | |